Latest filing published 06 Apr 2022 for MedAvail Holdings, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
ABG WTT-MedAvail Ltd appears in our data through filings on MedAvail Holdings, Inc. shares, published by SEC (Form 4). In total, 30 filings cover trades dated from 14 December 2020 to 4 April 2022.
Purchases make up the whole of the open-market record (30 purchases, €15.8M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €80k.
The newest entry dates from 6 April 2022: an open-market purchase of €2.9M, in MedAvail Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration